Relations between diabetic retinopathy and cardiovascular neuropatby - A cross-sectional study in IDDM and NIDDM patients

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue 6, 1997, Pages 319-326

  Zander, E ^a,c   Heinke, P ^b   Herfurth, S ^b   Reindel, J ^a   Ostermann, F E ^a   Kerner, W ^a  

^a Clinic for Diabetes and Metabolic Diseases   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c Klin F Diabet S   (Germany)

Author keywords

Autonomic neuropathy; Background retinopathy; IDDM; NIDDM; Proliferative retinopathy; Systemic risk factors

Indexed keywords

ALBUMIN; CHOLESTEROL;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BODY MASS; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RISK FACTOR;

EID: 0030775790     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211772     Document Type: Article

References (41)

1. Araki A, Ito H, Hattori A, Inoue J, Sato T, Shiraki M, Orino H: Risk factors for development of retinopathy in elderly Japanese patients with diabetes mellitus. Diabetes Care 16: 1184-1186, 1993
2. Cahill GF Jr., Etzwiler DD, Freinkel N: "Control" and diabetes. N Engl J Med (editorial) 294: 1004-1005, 1976
3. Caldwell G, Kohner EM: Diabetic retinopathy and nephropathy - Are they related? J Diab Compl: 3 137-138, 1989
4. Cicmir IJ, Grüneklee D, Morguet A, Berger H, Kley HK, Lehmacher W, Gries FA: Studies of heart rate oscillations in diabetics at rest. Horm Metab Res Suppl. Series 9: 73-76, 1980
5. Clark CV: Ocular autonomic nerve function in proliferative diabetic retinopathy. Eye 2: 96-104, 1988
6. Colwell JA: Effects of diabetic control on retinopathy. Diabetes 15: 497-499, 1966
7. Engerman RL, Bloodworth JMB, Nelson SL: Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26: 760-769, 1977
8. Engerman RL, Kern TS: Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36: 808-812, 1987
9. Eschwege E, Job D, Guyot-Argenton C, Aubry JP, Tchobroutsky G: Delayed progression of diabetic retinopathy by divided insulin administration, a further follow-up. Diabetologia 16: 13-15, 1979
10. Fallon TJ, Maxwell DL, Kohner EM: Autoregulation of retinal blood flow in diabetic retinopathy measured by the blue-light entoptic technique. Ophthalmology 94: 1410-1415, 1987
11. Fong DS, Warram JH, Aiello LM, Rand L-J, Krolewski AS.: Cardiovascular autonomic neuropathy and proliferative diabetic retinopathy. Am J Ophthalmol 120: 317-321, 1995
12. Furukawa H: Autonomic innervation of preretinal blood vessels of the rabbit. Invest Ophthalmol Vis Sci 28: 1752, 1987
13. Giardullo A, Ricordi L, Rossi M, Marti G, Vandelli G, Fratino P, Bernardi L: Relationship between retinal ischemia and cardivascular autonomic damage in diabetes. Acta Diabetol Lat 26: 245-255, 1989
14. Gottschling HD, Jahr D, Diaz-Alonso J-M, Keilacker H, Besch W, Werner S, Ziegler M: Enzymimmunoassay zur Bestimmung von Albumin im Urin. Z med Lab diagn 32: 84-90, 1991
15. Hanna AK, Roy M, Zinman B, Mc Culloch JC, Mortimer C, Falk JA, Chipman M, Gordon AS: In evaluation of factors associated with proliferative diabetic retinopathy. Clin Investig Med 8: 109-116, 1985
16. Hasslacher Ch, Terpsta J, Kunowski G, Gallesch G, Ritz E: Metabolic control and blood pressure as risk factors for proliferative retinopathy in proteinuric type 1 diabetes. Transplant Proc 18: 1572-1573, 1986
17. Henricsson M, Nilsson A, Janzon L, Groop L: The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabetic Medicine 14: 123-131, 1997
18. Karma A, Gummerus S, Kujansuu E, Pitajarvi T: Predicting diabetic retinopathy. Acta Ophthalmol. 65: 136-139, 1987
19. Klein BEK, Moss SE, Klein R, Surawicz TS: The Wisconsin Epidemiologic Study of diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exsudate. Ophthalmology 98: 1261-1265, 1991
20. Klein R, Klein BEK, Moss SE: Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15: 1875-1891, 1992
21. Klein R, Klein BEK, Moss SE, Davis MD, De Mets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526, 1984
22. Klein R, Klein BEK, Moss SE, Davis MD, De Mets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is less 30 or more years. Arch Ophthalmol 102: 527-532, 1984
23. Klein R, Klein BEK, Moss, SE, Davis MD, De Mets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy: V. proteinuria and retinopathy in a population of diabetic persons diagnosed prior to 30 years of age. In: Friedman, EA, L'Esperance, FA (eds.) Diabetic Renal-Retinal Syndrome. pp. 245-264, New York, Grune & Stratton, 1986.
24. Klein R, Klein BEK, Moss SE, De Mets DL: Proteinuria in diabetes. Arch Intern Med 148: 181-186, 1988
25. Knowler WC, Bennett P-H, Ballintine EJ: Increased incidence of retinopathy in diabetics with elevated blood pressure. N Engl J Med 302: 645-650, 1980
26. Kostraba JN, Klein R, Dorman JS, Becker DJ, Drash AL, Maser RE, Orchard TJ: The Epidemiology of Diabetes Complications Study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol 133: 381-391, 1991
27. Lorini R, Larizza D, Livieri C, Camareri V, Zandrini C, Severi F: Relationship between nerve function, retinopathy, and duration of diabetes. Eur J Pediatr 145: 580-581, 1986
28. Mohnike G: "Einführende Bemerkungen über die Retinopathia diabetica in internistischer Sicht". Mohnike, G. (ed.) Diabetische Angiopathie: I. Internationales Symposium über Diabetesfragen 1962 im Institut für Diabetes, Forschung und Behandlung "Gerhardt Katsch", Karlsburg/Greifswald. pp. 9-10, Akademie-Verl., 1964.
29. Murray A, Ewing DJ, Campbell IW, Neilson JNM, Clarke BF: R-R variations in young male diabetics. Brit Heart J 37: 882-885, 1975
30. Patel V, Rassam S, Newsom R, Wiek J, Kohner E: Retinal blood flow in diabetic retinopathy. Brit med J 305: 678-683, 1992
31. Ramsey RC, Knobloch WH, Cantrell HL, Comty CM, Najarian JS, Goetz FC: Visual status in transplanted and dialyzed diabetic patients. In: Friedman EA, L'Espérance FA (eds): Prevention and management: Diabetic Renal-Retinal-Syndrome. pp. 427-435, New York, Grune & Stratton, 1982.
32. Seidlein I, Herfurth S: Klinisches Bild, Diagnostik, Klassifikation und Epidemiologie der diabetischen Retinopathie. Augenoptik (Berlin) 107: 7-9, 1990
33. Smith SE, Smith SA, Brown PM: Cardiac autonomic dysfunction in patients with diabetic retinopathy. Diabetologia 2: 525, 1981
34. The DCCT Research Group: The Diabetes Control and Complications Trial (DCCT): Design and methodologic considerations for the feasibility phase. Diabetes 35: 530-545, 1986
35. The DCCT Research Group: Diabetes Control and Complications Trial (DCCT): Update. Diabetes Care 13: 427-433, 1990
36. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
37. Vigstrup I, Mogensen CE: Proliferative diabetic retinopathy at risk patients identified by early detection of microalbuminuria. Acta Ophthalmol. 63: 530-534, 1985
38. West KM, Erdreich LJ, Stober JA: A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 29: 501-508, 1980
39. Willms B, Standl E: Die DCCT beherrscht den Amerikanischen Diabeteskongreß 1993. Diab Stoffw 2: 403-407, 1993
40. Zander E, Heinke P, Gottschling D, Herrmann U, Michaelis D, Kerner W: Die Beziehungen der Albuminexkretion zu Mikro- und Makroangiopathie und zum kardiovaskulären Risikoprofil beim Typ- I- und Typ-II-Diabetes. Diab Stoffw 6: 51-58, 1997
41. Zander E, Seidlein I, Herfurth S, Heinke P, Chlup R, Badendick K, Strese J, Zander G, Schulz B: Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria. Exp Clin Endocrinol 99: 102-07, 1992